Eugene Major, PhD: JC virus levels and the risk for PML with Tysabri
The HCC interviewed the Chief of the labs at the NIH that tests samples of patients who develop PML while on Tysabri, Dr. Major. This lab gives data and advice to the FDA. Dr. Major wrote the recent perspective in the NEJM. Viremia of JC virus is currently not a risk factor for PML and serial testing for JC levels is not part of the TOUCH risk management program.
Infectious Disease, Internal medicine, Multiple Sclerosis, NEJM, Neurology, NIH, Radiology | apples49 | 
September 29, 2009 10:40 am
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
